Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Wang L, Volkow ND, Berger NA, Davis PB, Kaelber DC, Xu R Association of COVID-19 with endocarditis in patients with cocaine or opioid use disorders in the US
Peptides don't immediately enter systemic circulation
PubMed laboratory research record [PMID: 11595456] PubMed record related to this compound for laboratory literature review
28 note to investors, William Blair analysts wrote that Applied Therapeutics suspects the CRL was related to the efficacy package as opposed to [chemistry, manufacturing and controls] or safety. Results from the Phase III ACTION-Galactosemia Kids study, unveiled in April 2023, showed that govorestat fell short of its primary efficacy endpoint, a composite of four clinical measures designed to assess various domains of galactosemia symptoms
US$ 24.84
US$ 28.66
US$ 24.64
US$ 27.35
US$ 20.21
US$ 21.34
US$ 25.07
US$ 25.56
